This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Abraham, Fruchter & Twersky, LLP Announces The Filing Of A Class Action Lawsuit Against ZELTIQ Aesthetics, Inc.

Abraham, Fruchter & Twersky, LLP has filed a class action lawsuit against ZELTIQ Aesthetics, Inc. (“ZELTIQ” or the “Company”)(NASDAQ: ZLTQ) arising out of the sale of the Company’s common stock in an initial public offering (“IPO”) which commenced on October 19, 2011. The Complaint alleges that the Company and its senior executives failed to disclose material adverse facts concerning disruptions in sales and a resulting deceleration in the Company’s growth rate. These facts were ultimately and belatedly disclosed on March 6, 2012, causing the price of the Company’s common stock to drop precipitously to close at $7.36 per share, a decline of more than 40% from the IPO price of $13.00 per share.

If you purchased or otherwise acquired ZELTIQ common stock in connection with the IPO and you would like to discuss this action or have any questions concerning your rights as a potential class member or lead plaintiff, you may contact: Jeffrey S. Abraham or Philip T. Taylor of Abraham, Fruchter & Twersky, LLP, One Penn Plaza, Suite 2805, New York, New York 10119, by telephone at (800) 440-8986, by facsimile at (212) 279-3655 or by e-mail at, respectively, jabraham@aftlaw.com or ptaylor@aftlaw.com.

For more information concerning Abraham, Fruchter & Twersky, LLP, please visit our website at www.aftlaw.com.



Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,070.40 +46.34 0.26%
S&P 500 2,114.49 +6.20 0.29%
NASDAQ 5,016.9290 +11.5380 0.23%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs